Haptoglobin genotype and the iron hypothesis of atherosclerosis
- 31 May 2011
- journal article
- comment
- Published by Elsevier BV in Atherosclerosis
- Vol. 216 (1), 17-18
- https://doi.org/10.1016/j.atherosclerosis.2011.01.029
Abstract
No abstract availableKeywords
Funding Information
- JDRF
- BSF
- NIH (RO1DK085226)
This publication has 23 references indexed in Scilit:
- Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaquesAtherosclerosis, 2011
- Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotypePharmacogenomics, 2010
- Haptoglobin: Basic and Clinical AspectsAntioxidants and Redox Signaling, 2010
- Iron in arterial plaque: A modifiable risk factor for atherosclerosisBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunctionPharmacogenomics and Personalized Medicine, 2009
- Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 GenotypeDiabetes, 2008
- Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 GenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Haptoglobin Polymorphism Predicts 30-Day Mortality and Heart Failure in Patients With Diabetes and Acute Myocardial InfarctionDiabetes, 2005
- Haptoglobin Genotype Is Predictive of Major Adverse Cardiac Events in the 1-Year Period After Percutaneous Transluminal Coronary Angioplasty in Individuals With DiabetesDiabetes Care, 2003
- Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the strong heart studyJournal of the American College of Cardiology, 2002